Table 3 Reported adherence to the ERP components
Braga 2017 [19] | Braga 2016 [20] | Gonzalez-Ayora 2016 [21] | Pedziwiatr 2015 [22] | Kisialeuski 2015 [23] | Feroci 2013 [26] | Pawa 2012 [29] | Rumstadt 2009 [32] | Scharfen-berg 2007 [34] | range | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
71-75y | 76-80y | > 80y | ≥ 70y, ASA 1,2 | ≥ 70y, ASA 3,4 | ≥ 70y | ≥ 80y | > 65y | ≥75y | ≥ 80y | 70-79y | ≥80 y | >70y | ||
n = 105 | n = 117 | n = 93 | n = 167 | n = 162 | n = 188 | n = 34 | n = 49 | n = 204 | n = 130 | n = 535 | n = 207 | n = 74 | ||
1.Pre-admission counselling | 100 | 99 | 97 | 100 | 100 | 100 | 100 | 97–100 | ||||||
3.No bowel preparation | 90 | 86 | 90 | 91 | 85 | 80 | 100 | / | 80 | 83 | / | 80–100 | ||
4a.Limited pre-operative fasting time | / | / | / | / | / | / | / | / | 100 | / | / | / | / | |
4b.Carbohydrate loading | 80 | 81 | 82 | 87 | 73 | 100 | 77 | / | / | / | / | 73–100 | ||
5.No sedative premedication | 40 | 44 | 40 | 40 | 40 | / | / | / | 100 | / | / | / | / | 40–100 |
6.Antithrombotic prophylaxis | 100 | 100 | 100 | 100 | 100 | 100 | 100 | / | / | / | 100 | |||
7.Antimicrobial prophylaxis | 100 | 100 | 100 | 100 | 100 | 100 | 100 | / | / | 100 | ||||
9.PONV prophylaxis | 73 | 66 | 88 | 88 | 61 | / | 60 | / | 93 | 95 | / | 60–95 | ||
10.Minimal invasive surgery | / | / | / | / | / | / | / | / | / | 93 | 39 | 25 | / | 25–93 |
11.No nasogastric tube | 91 | 93 | 90 | 92 | 92 | 100 | 100 | 90–100 | ||||||
12.Active warming | 99 | 97 | 95 | 100 | 100 | / | / | 100 | / | / | / | 95–100 | ||
13.Peri-operative fluid management | 92 | / | ||||||||||||
- Intra-operative fluids (mean ± SD or median and IQR, in ml/kg/h) | 9.7 (±4.1) | 8.5 (±4.0) | 10.3 (±5.9) | 7.2 (4.8–10.1) | 8.9 (6.1–12.6) | 7.2–10.3 | ||||||||
- Infusion < 3000 ml during surgery | 87 | 81 | 81–87 | |||||||||||
- Stop IV fluid POD 1 | 73 | / | 24 | 75 | 62 | 24–75 | ||||||||
- Stop IV fluid POD 2 | 74 | 67 | 60 | 70 | 67 | 60–74 | ||||||||
14.No abdominal drain | 30 | 33 | 44 | 37 | 31 | 43 | 80 | / | / | 30–80 | ||||
15.Early (per protocol) UC removal | 70 | 67 | 69 | 78 | 62 | 65 | 80 | 64 | 56 | 56–80 | ||||
17.Multimodal opioid sparing analgesia | ||||||||||||||
- Non-opioid based analgesia | 74 | 92 | 89 | 74–92 | ||||||||||
- Epidural analgesia | 50 | 51 | 58 | 61 | 43 | 62 | 55 | 86 | 86 | 43–86 | ||||
- Epidural catheter removal ≤ POD 3 | 36 | 38 | 47 | 78 | 75 | 69 | 36–78 | |||||||
18.Early oral intake | ||||||||||||||
- Oral liquids POD 0 | 59 | 59 | 49 | 56 | 57 | 75 | 69 | 84 | 49–84 | |||||
- Oral liquids POD 1 | 90 | 92 | 90 | 87 | 46 | 46–92 | ||||||||
- Oral liquids POD 0–1 | 84 | |||||||||||||
- Solid food POD 1 | 53 | 57 | 52 | 52 | 57 | 82 | 73 | 60 | 51 | 86 | 51–86 | |||
- Solid food POD 2 | 77 | 86 | 82 | 92 | 39 | 39–92 | ||||||||
20.Early mobilisation | ||||||||||||||
- Out of bed POD 0 | 90 | 60 | 71 | 55 | 55–90 | |||||||||
- Out of bed POD 1 | 93 | 91 | 89 | 95 | 86 | 94 | 55 | 20 | 69 | 53 | 20–95 | |||
Global Compliance | 661 | 561 | 562 | 853 | 56–85 | |||||||||